InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
14%
T+90 mean return
-18.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lachance Carrie, Présidente et Directrice des opérations. Officer active across 2 companies, notably InfuSystem Holdings, Inc. Aggregated, 13 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €26k. Activity tracked since 18 May 2021. The latest transaction was filed on 17 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations13 total
17,727 shares0Common StockSEC:0001628280-25-026955:0
1,165 shares@ US$6.0055.1% of flowCommon StockSEC:0001628280-25-026388:0
Canonical exit: 13 Aug 2025 (T+90)
5,052 shares0Common StockSEC:0001628280-24-024603:0
50,000 shares0Common StockSEC:0001628280-24-009231:0
25,000 shares@ US$3.3663.0% of flowCommon StockSEC:0001628280-23-024142:0
3,000 shares@ US$6.816515.7% of flowCommon StockSEC:0001628280-23-008632:0
Canonical exit: 15 Jun 2023 (T+90)
10,000 shares@ US$1.9816.2% of flowCommon StockSEC:0001628280-22-024410:0
10,000 shares0Common StockSEC:0001628280-22-015216:0
2,821 shares0Common StockSEC:0001628280-22-015081:0
10,000 shares0Common StockSEC:0001014108-21-000187:0
10,000 shares0Common StockSEC:0001014108-21-000187
00Common StockSEC:0001014108-21-000118
Canonical exit: 16 Aug 2021 (T+90)
00Common StockSEC:0001014108-21-000118:0
Canonical exit: 16 Aug 2021 (T+90)
13 of 13 declarations
About Lachance Carrie
Carrie Lachance is the President and COO of InfuSystem Holdings, Inc. She is responsible for the operational leadership of the company, overseeing its activities and growth initiatives. Her leadership is essential in ensuring the success of InfuSystem in the healthcare sector.
